Patents
Literature
1 results about "Specific immunotherapy" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Allergen-specific immunotherapy is indicated in patients with allergic rhinitis/conjunctivitis and/or allergic asthma who have evidence of specific IgE antibodies to clinically relevant allergens (see Table 1). Skin prick testing (SPT) is the preferred method of testing for specific IgE antibodies.
A method for treating allergies and enhancing allergen-specific immunotherapy by administering IL-4R antagonists.
PendingJP2026086598AAllergen ingredientsAntibody ingredientsAntiendomysial antibodiesAntigen Binding Fragment
This invention provides a method for enhancing the efficacy, safety, and / or tolerance of grass allergen-specific subcutaneous immunotherapy (SCIT) regimens in subjects with grass allergies. [Solution] A method is provided which includes administering a therapeutic composition containing an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or its antigen-binding fragment, to a subject in need.
Owner:REGENERON PHARMACEUTICALS INC +1